• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与前列腺炎症和下尿路症状相关的炎症机制

Inflammatory Mechanisms Associated with Prostatic Inflammation and Lower Urinary Tract Symptoms.

作者信息

St Sauver Jennifer L, Jacobsen Steven J

出版信息

Curr Prostate Rep. 2008 May 1;6(2):67-73. doi: 10.1007/s11918-008-0011-5.

DOI:10.1007/s11918-008-0011-5
PMID:19809538
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2757322/
Abstract

Inflammation is a common finding in histologic prostate specimens obtained from aging men, and accumulating data suggest that inflammation may play an important role in the development of benign prostatic hyperplasia (BPH), and the development and progression of lower urinary tract symptoms (LUTS). Inflammatory processes may contribute to prostatic enlargement directly through stimulation of prostate growth, or, alternatively, through decreasing prostatic apoptosis. Additionally, inflammatory processes may impact other components of the urogenital tract, such as the bladder, and contribute to the LUTS that may be experienced both in the presence and in the absence of prostate enlargement. Current research therefore offers clues about converging inflammatory pathways which may be targeted to improve treatment of BPH and/or LUTS as well as identifying potential targets for prevention of these syndromes.

摘要

炎症是从老年男性获取的前列腺组织学标本中的常见表现,越来越多的数据表明,炎症可能在良性前列腺增生(BPH)的发生以及下尿路症状(LUTS)的发生和进展中起重要作用。炎症过程可能通过刺激前列腺生长直接导致前列腺肿大,或者通过减少前列腺细胞凋亡来实现。此外,炎症过程可能影响泌尿生殖道的其他组成部分,如膀胱,并导致无论前列腺是否肿大都可能出现的LUTS。因此,当前的研究为汇聚的炎症途径提供了线索,这些途径可能成为改善BPH和/或LUTS治疗的靶点,同时也有助于确定预防这些综合征的潜在靶点。

相似文献

1
Inflammatory Mechanisms Associated with Prostatic Inflammation and Lower Urinary Tract Symptoms.与前列腺炎症和下尿路症状相关的炎症机制
Curr Prostate Rep. 2008 May 1;6(2):67-73. doi: 10.1007/s11918-008-0011-5.
2
A new experimental rat model of erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: the testosterone-supplemented spontaneously hypertensive rat.一种新型与良性前列腺增生相关的勃起功能障碍和下尿路症状的实验性大鼠模型:补充睾酮的自发性高血压大鼠。
BJU Int. 2012 Nov;110(9):1352-8. doi: 10.1111/j.1464-410X.2012.11085.x. Epub 2012 Mar 27.
3
Inflammation is a target of medical treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia.炎症是治疗与良性前列腺增生相关的下尿路症状的医学靶点。
World J Urol. 2020 Nov;38(11):2771-2779. doi: 10.1007/s00345-020-03106-1. Epub 2020 Feb 14.
4
The influence of asymptomatic inflammatory prostatitis on the onset and progression of lower urinary tract symptoms in men with histologic benign prostatic hyperplasia.无症状性炎症性前列腺炎对组织学诊断为良性前列腺增生的男性下尿路症状发生及进展的影响。
Asian J Urol. 2017 Jul;4(3):158-163. doi: 10.1016/j.ajur.2017.02.004. Epub 2017 May 25.
5
The prostaglandin pathway is activated in patients who fail medical therapy for benign prostatic hyperplasia with lower urinary tract symptoms.前列腺素途径在接受药物治疗失败的良性前列腺增生症伴下尿路症状患者中被激活。
Prostate. 2021 Sep;81(13):944-955. doi: 10.1002/pros.24190. Epub 2021 Jul 20.
6
The role of prostate inflammation and fibrosis in lower urinary tract symptoms.前列腺炎症和纤维化在下尿路症状中的作用。
Am J Physiol Renal Physiol. 2016 Oct 1;311(4):F817-F821. doi: 10.1152/ajprenal.00602.2015. Epub 2016 Jul 20.
7
Non-steroidal anti-inflammatory drug use and the risk of benign prostatic hyperplasia-related outcomes and nocturia in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.非甾体抗炎药的使用与前列腺、肺、结直肠和卵巢癌筛查试验中良性前列腺增生相关结局和夜尿症的风险。
BJU Int. 2012 Oct;110(7):1050-9. doi: 10.1111/j.1464-410X.2011.10867.x. Epub 2012 Mar 19.
8
The role of inflammation in lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) and its potential impact on medical therapy.炎症在良性前列腺增生(BPH)所致下尿路症状(LUTS)中的作用及其对药物治疗的潜在影响。
Curr Urol Rep. 2014 Dec;15(12):463. doi: 10.1007/s11934-014-0463-9.
9
The urinary and prostatic microbiome in non-neurogenic male LUTS/BPH: A systematic review.非神经源性男性下尿路症状/良性前列腺增生中的泌尿和前列腺微生物群:一项系统综述。
Neurourol Urodyn. 2024 Nov;43(8):1938-1947. doi: 10.1002/nau.25530. Epub 2024 Jun 27.
10
Benign prostatic hyperplasia nodules in patients treated with celecoxib and/or finasteride have reduced levels of NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, a mitochondrial protein essential for efficient function of the electron transport chain.接受塞来昔布和/或非那雄胺治疗的前列腺增生患者的前列腺增生结节中,烟酰胺腺嘌呤二核苷酸脱氢酶[泛醌]铁硫蛋白 3 的水平降低,这种蛋白是电子传递链有效功能所必需的线粒体蛋白。
Prostate. 2024 Oct;84(14):1309-1319. doi: 10.1002/pros.24766. Epub 2024 Jul 14.

引用本文的文献

1
Asiatic acid mitigates testosterone-induced benign prostatic hyperplasia in rats via activation of PPAR-γ.齐墩果酸通过激活PPAR-γ减轻睾酮诱导的大鼠良性前列腺增生。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Feb;398(2):1991-2001. doi: 10.1007/s00210-024-03405-z. Epub 2024 Sep 2.
2
Association between trichomoniasis and prostate and bladder diseases: a population-based case-control study.滴虫病与前列腺和膀胱疾病的关联:一项基于人群的病例对照研究。
Sci Rep. 2022 Sep 13;12(1):15358. doi: 10.1038/s41598-022-19561-2.
3
IL-27/IL-27RA signaling may modulate inflammation and progression of benign prostatic hyperplasia via suppressing the LPS/TLR4 pathway.白细胞介素-27/白细胞介素-27受体信号通路可能通过抑制脂多糖/ Toll样受体4途径来调节良性前列腺增生的炎症反应和进展。
Transl Cancer Res. 2020 Aug;9(8):4618-4634. doi: 10.21037/tcr-20-1509.
4
Signaling Role of Adipocyte Leptin in Prostate Cell Proliferation Induced by Trichomonas vaginalis.脂肪细胞瘦素在阴道毛滴虫诱导的前列腺细胞增殖中的信号作用。
Korean J Parasitol. 2021 Jun;59(3):235-249. doi: 10.3347/kjp.2021.59.3.235. Epub 2021 Jun 21.
5
Dietary Carcinogens and DNA Adducts in Prostate Cancer.膳食中的致癌物质与前列腺癌中的 DNA 加合物。
Adv Exp Med Biol. 2019;1210:29-55. doi: 10.1007/978-3-030-32656-2_2.
6
Statin Use, Serum Lipids, and Prostate Inflammation in Men with a Negative Prostate Biopsy: Results from the REDUCE Trial.前列腺活检阴性男性的他汀类药物使用、血脂与前列腺炎症:REDUCE试验结果
Cancer Prev Res (Phila). 2017 Jun;10(6):319-326. doi: 10.1158/1940-6207.CAPR-17-0019. Epub 2017 May 9.
7
CXCL12/CXCR4 Axis Activation Mediates Prostate Myofibroblast Phenoconversion through Non-Canonical EGFR/MEK/ERK Signaling.CXCL12/CXCR4轴激活通过非经典EGFR/MEK/ERK信号传导介导前列腺肌成纤维细胞表型转化。
PLoS One. 2016 Jul 19;11(7):e0159490. doi: 10.1371/journal.pone.0159490. eCollection 2016.
8
Evaluation of survivin expression in prostate specimens of patients with prostate adenocarcinoma and benign prostate hyperplasia underwent transurethral resection of the prostate or prostatectomy.对接受经尿道前列腺切除术或前列腺切除术的前列腺腺癌和良性前列腺增生患者的前列腺标本中的生存素表达进行评估。
Springerplus. 2016 May 14;5:621. doi: 10.1186/s40064-016-2283-5. eCollection 2016.
9
Inflammatory Signaling Involved in High-Fat Diet Induced Prostate Diseases.高脂饮食诱导的前列腺疾病中涉及的炎症信号传导
J Urol Res. 2015 Jan 1;2(1). Epub 2015 Jan 12.
10
Beta-catenin is elevated in human benign prostatic hyperplasia specimens compared to histologically normal prostate tissue.与组织学正常的前列腺组织相比,β-连环蛋白在人类良性前列腺增生标本中含量升高。
Am J Clin Exp Urol. 2014 Dec 25;2(4):313-22. eCollection 2014.

本文引用的文献

1
Examination of the relationship between symptoms of prostatitis and histological inflammation: baseline data from the REDUCE chemoprevention trial.前列腺炎症状与组织学炎症之间的关系研究:REDUCE化学预防试验的基线数据
J Urol. 2007 Sep;178(3 Pt 1):896-900; discussion 900-1. doi: 10.1016/j.juro.2007.05.041. Epub 2007 Jul 16.
2
Does intraprostatic inflammation have a role in the pathogenesis and progression of benign prostatic hyperplasia?前列腺内炎症在良性前列腺增生的发病机制及进展过程中起作用吗?
BJU Int. 2007 Aug;100(2):327-31. doi: 10.1111/j.1464-410X.2007.06910.x.
3
Is benign prostatic hyperplasia (BPH) an immune inflammatory disease?良性前列腺增生(BPH)是一种免疫炎症性疾病吗?
Eur Urol. 2007 May;51(5):1202-16. doi: 10.1016/j.eururo.2006.12.011. Epub 2006 Dec 11.
4
Protective association between nonsteroidal antiinflammatory drug use and measures of benign prostatic hyperplasia.非甾体抗炎药使用与良性前列腺增生指标之间的保护关联。
Am J Epidemiol. 2006 Oct 15;164(8):760-8. doi: 10.1093/aje/kwj258. Epub 2006 Aug 11.
5
Seminal plasma cytokines and chemokines in prostate inflammation: interleukin 8 as a predictive biomarker in chronic prostatitis/chronic pelvic pain syndrome and benign prostatic hyperplasia.前列腺炎症中的精浆细胞因子和趋化因子:白细胞介素8作为慢性前列腺炎/慢性盆腔疼痛综合征和良性前列腺增生的预测生物标志物。
Eur Urol. 2007 Feb;51(2):524-33; discussion 533. doi: 10.1016/j.eururo.2006.07.016. Epub 2006 Jul 28.
6
Relation between acute urinary retention, chronic prostatic inflammation and accompanying elevated prostate-specific antigen.急性尿潴留、慢性前列腺炎与伴发的前列腺特异性抗原升高之间的关系。
Scand J Urol Nephrol. 2006;40(2):155-60. doi: 10.1080/00365590500497960.
7
Effect of cyclooxygenase inhibitors on the micturition reflex in rats: correlation with inhibition of cyclooxygenase isozymes.环氧化酶抑制剂对大鼠排尿反射的影响:与环氧化酶同工酶抑制作用的相关性。
BJU Int. 2006 Apr;97(4):837-46. doi: 10.1111/j.1464-410X.2006.06003.x.
8
Relationship between serum prostate specific antigen and the pattern of inflammation in both benign and malignant prostatic disease in Middle Eastern men.中东男性良性和恶性前列腺疾病中血清前列腺特异性抗原与炎症模式的关系
Int Urol Nephrol. 2006;38(1):27-32. doi: 10.1007/s11255-005-3618-2.
9
Tracking of longitudinal changes in measures of benign prostatic hyperplasia in a population based cohort.基于人群队列的良性前列腺增生测量指标纵向变化追踪。
J Urol. 2006 Mar;175(3 Pt 1):1018-22; discussion 1022. doi: 10.1016/S0022-5347(05)00408-8.
10
Human detrusor smooth muscle cells release interleukin-6, interleukin-8, and RANTES in response to proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha.人逼尿肌平滑肌细胞在促炎细胞因子白细胞介素-1β和肿瘤坏死因子-α的刺激下释放白细胞介素-6、白细胞介素-8和调节激活正常T细胞表达和分泌的因子。
Urology. 2006 Jan;67(1):214-9. doi: 10.1016/j.urology.2005.07.049.